Patents by Inventor Chia-Ni Lin

Chia-Ni Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AGAINST INFLUENZA A VIRAL INFECTION WITH TRYPTOPHAN AND ARGININE
    Publication number: 20190275002
    Abstract: Disclosed herein is a method against influenza A viral infection, including administering to a subject in need thereof tryptophan and arginine.
    Type: Application
    Filed: August 3, 2018
    Publication date: September 12, 2019
    Inventors: Chia-Ni LIN, Ching-Hwa TSAI, Sue-Jane LIN
  • Recombinant human factor IX and use thereof
    Patent number: 7888067
    Abstract: The present invention aims at converting factor IX into a molecule with enhanced activity which provides an alternative for replacement therapy and gene therapy for hemophilia B. Using recombinant techniques, factor IX with replacement at positions 86, 277, and 338 exhibits better clotting activity than recombinant wild type factor IX.
    Type: Grant
    Filed: November 23, 2009
    Date of Patent: February 15, 2011
    Inventors: Shu-Wha Lin, Chia-Ni Lin, Hua-Lin Wu, Guey-Yueh Shi
  • Recombinant human factor IX and use thereof
    Patent number: 7700734
    Abstract: The present invention aims at converting factor IX into a molecule with enhanced activity which provides an alternative for replacement therapy and gene therapy for hemophilia B. Using recombinant techniques, factor IX having substitution of amino acid residue of SEQ ID NO: 7 at amino acid position selected from the group consisting of 86, 277, and 338 (exclude the circumstance of a single substitution at amino acid position 338) exhibits better clotting activity than recombinant wild type factor IX.
    Type: Grant
    Filed: November 6, 2007
    Date of Patent: April 20, 2010
    Inventors: Shu-Wha Lin, Chia-Ni Lin, Hua-Lin Wu, Guey-Yueh Shi
  • RECOMBINANT HUMAN FACTOR IX AND USE THEREOF
    Publication number: 20100081712
    Abstract: The present invention aims at converting factor IX into a molecule with enhanced activity which provides an alternative for replacement therapy and gene therapy for hemophilia B. Using recombinant techniques, factor IX with replacement at positions 86, 277, and 338 exhibits better clotting activity than recombinant wild type factor IX.
    Type: Application
    Filed: November 23, 2009
    Publication date: April 1, 2010
    Inventors: Shu-Wha Lin, Chia-Ni Lin, Hua-Lin Wu, Guey-Yueh Shi
  • RECOMBINANT HUMAN FACTOR IX AND USE THEREOF
    Publication number: 20080167219
    Abstract: The present invention aims at converting factor IX into a molecule with enhanced activity which provides an alternative for replacement therapy and gene therapy for hemophilia B. Using recombinant techniques, factor IX with replacement at positions 86, 277, and 338 exhibits better clotting activity than recombinant wild type factor IX.
    Type: Application
    Filed: November 6, 2007
    Publication date: July 10, 2008
    Inventors: Shu-Wha Lin, Chia-Ni Lin, Hua-Lin Wu, Guey-Yueh Shi